| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.4 | 2e-14 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-11 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.34 | 3e-10 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-06 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |